Virginia Retirement Systems’s PTC Therapeutics PTCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.32M Buy
28,450
+1,700
+6% +$123K 0.01% 506
2026
Q1
$1.82M Sell
26,750
-4,100
-13% -$290K 0.01% 452
2025
Q4
$2.34M Sell
30,850
-6,100
-17% -$443K 0.01% 391
2025
Q3
$2.27M Buy
36,950
+5,300
+17% +$276K 0.01% 399
2025
Q2
$1.55M Buy
31,650
+11,200
+55% +$532K 0.01% 459
2025
Q1
$1.04M Buy
+20,450
New +$1.02M 0.01% 546
2023
Q3
$211K Sell
9,400
-3,300
-26% -$123K ﹤0.01% 873
2023
Q2
$517K Buy
+12,700
New +$621K 0.01% 713
2023
Q1
Sell
-10,600
Closed -$405K 1189
2022
Q4
$405K Sell
10,600
-1,400
-12% -$58.2K ﹤0.01% 882
2022
Q3
$602K Buy
+12,000
New +$588K 0.01% 754
2021
Q1
Sell
-4,400
Closed -$269K 1177
2020
Q4
$269K Buy
+4,400
New +$259K ﹤0.01% 998
2020
Q3
Sell
-4,800
Closed -$244K 1157
2020
Q2
$244K Buy
+4,800
New +$236K ﹤0.01% 990
2019
Q4
Sell
-17,400
Closed -$588K 1184
2019
Q3
$588K Sell
17,400
-700
-4% -$30.5K 0.01% 858
2019
Q2
$815K Hold
18,100
0.01% 740
2019
Q1
$681K Sell
18,100
-2,500
-12% -$83.9K 0.01% 808
2018
Q4
$707K Hold
20,600
0.01% 754
2018
Q3
$968K Sell
20,600
-27,600
-57% -$1.14M 0.01% 722
2018
Q2
$1.63M Buy
+48,200
New +$1.5M 0.02% 510
2017
Q4
Sell
-18,700
Closed -$374K 1045
2017
Q3
$374K Buy
18,700
+300
+2% +$5.87K ﹤0.01% 863
2017
Q2
$337K Sell
18,400
-600
-3% -$8.08K ﹤0.01% 922
2017
Q1
$187K Buy
+19,000
New +$230K ﹤0.01% 1078
2015
Q2
Sell
-3,800
Closed -$231K 1026
2015
Q1
$231K Buy
+3,800
New +$232K ﹤0.01% 910

Other funds holding PTCT

Virginia Retirement Systems's PTCT Position: Q2 2026 in Review

Virginia Retirement Systems increased its PTC Therapeutics (PTCT) stake by 6.4% in Q2 2026, buying an estimated $123K and bringing the position to 28,450 shares worth $2.32M. The position accounts for 0.01% of the portfolio, ranked #506.

Virginia Retirement Systems first reported a position in PTCT in Q1 2015 and has held it in 22 quarters since. The position peaked at $2.34M in Q4 2025. 382 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.

  • Virginia Retirement Systems held 28,450 shares of PTC Therapeutics worth $2.32M as of Q2 2026.
  • Virginia Retirement Systems bought 1,700 PTC Therapeutics shares in Q2 2026, an estimated $123K.
  • PTC Therapeutics made up 0.01% of Virginia Retirement Systems's portfolio in Q2 2026, its #506 holding.
  • Virginia Retirement Systems first reported a position in PTC Therapeutics in Q1 2015 and has held it in 22 quarters since.
  • Virginia Retirement Systems's PTC Therapeutics position peaked at $2.34M in Q4 2025.
  • 382 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.

Based on Virginia Retirement Systems's 13F filing for Q2 2026, filed 25 Aug 2026.